Standard of Care and Treatment Strategy

Treating eumycetoma is a long-term commitment that requires individualized, specialist-led care between you, your infectious disease specialist, and your surgeon ^[1]. Because the fungus is highly resilient and resides within hard grains, treatment is generally a dual-pronged approach: using powerful antifungal medicine combined with surgery ^[2][3]. However, this is individualized; small, localized lesions might be treated with excision alone, while unresectable disease may be managed mostly medically.

Systemic Antifungal Therapy

The first line of defense is prolonged systemic antifungal therapy ^[1]. This means taking medication that travels through your bloodstream to reach the infection site ^[3].

• Itraconazole: This is commonly considered a standard treatment for eumycetoma ^[1]. A typical dose is 200 mg taken twice daily (totaling 400 mg per day), but the treating specialist selects the regimen ^[3]. Do not start, stop, or change the dose yourself.
• The Timeline: You will likely need to take this medication for at least 12 months ^[2]. In many successful treatment plans, patients take the medicine for several months before surgery to shrink the mass and for several months after surgery to treat any remaining fungal cells ^[2][4].
• Monitoring: Because you will be on this medicine for a long time, your doctor will perform regular blood tests to check your liver function ^[2].

In one randomized trial of selected patients with Madurella mycetomatis lesions up to 16 cm, complete cure at month 12 occurred in approximately 75% of those receiving itraconazole and surgery ^[2][5]. However, outcomes vary substantially by lesion extent, species, and follow-up.

Surgical Intervention

Surgery for eumycetoma is tailored based on depth, anatomic extent, and function. It requires physically removing infected tissue and fungal grains ^[6].

1. Wide Local Excision (WLE): If the infection is localized and resectable, surgeons perform a WLE ^[6]. They remove the entire mass along with a “safety margin” of healthy tissue ^[7].
2. Limb-Sparing Surgery and Reconstruction: For larger infections, surgeons may use skin grafts or tissue flaps to close the wound after the tissue is removed ^[7].
3. Amputation: This is considered a last resort. It may be necessary if the infection has caused extensive osteomyelitis (bone destruction) or advanced unresectable disease leaving no viable limb-sparing option ^[6][8]. Severe secondary infection does not automatically mean amputation; decisions involve multidisciplinary assessment. Modern imaging like MRI helps surgeons determine if the limb can be saved ^[9].

Defining a Complete Cure

Because eumycetoma has a risk of recurrence (coming back), doctors use a careful definition for a “complete cure” ^[10]. Clinicians define response individually using symptoms, examination, imaging when indicated, and laboratory results in context. While clinical trials might require total disappearance of the mass, normal ultrasound or MRI, and negative fungal cultures ^[2], in general practice, residual scar or inflammatory imaging changes may persist and do not necessarily mean active infection.

Even after treatment, you will need to be monitored by your doctor. In one large study of M. mycetomatis patients, about 27% experienced a recurrence after surgery, sometimes years later ^[10][11]. Consistent follow-up is your best defense against the infection returning ^[12].